United States Pharmaceuticals

Teva Pharmaceutical Industries Ltd (TEVA)

Track

Over the past 90 days, Teva Pharmaceutical Industries Ltd has seen significant insider selling activity, totaling approximately $31.2 million. Key executives, including the CEO, CFO, and EVP of Global Operations, have executed various planned and proposed sales. These transactions occurred following the company's recent results financiers, with the stock price showing a modest 0.7% change.
Ticker: TEVA Exchange: TLV
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 3 Aug 2026
Value US$3,254,931.37 | Price 261.27 | Shares 3,518 (-27.4%)
Proposed sale 3 Aug 2026
Value US$4,530,080.60 | Price 300.27 | Shares 80,333
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-05 2026-08-03 PlS Planned sale
Jover Placid

See "Remarks"

Officer
3,518 -27.4%
261.27
US$3,254,931 		3,518 -27.4% 261.27 US$3,254,931
2026-08-05 2026-08-03 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
6,641 -21.9%
458.77
US$1,687,611 		6,641 -21.9% 458.77 US$1,687,611
2026-08-03 2026-08-03 PrS Proposed sale
Jover Placid

Executive VP, Chief HR Officer

Officer
80,333
300.27
US$4,530,081 		80,333 300.27 US$4,530,081
2026-08-03 2026-08-03 PrS Proposed sale
Hughes Eric A

Executive VP Global R&D and Chief Med Officer

Officer
1,000
34.88
US$100,000 		1,000 34.88 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
Hughes Eric A

Executive VP Global R&D and Chief Med Officer

Officer
1,000
34.88
US$100,000 		1,000 34.88 US$100,000
2026-06-22 2026-06-18 S Sale
Shields Matthew

EVP, Global Operations

Officer
9,989 -100.0%
32.19
US$321,547 		9,989 -100.0% 32.19 US$321,547
2026-06-22 2026-06-18 S Sale
Shields Matthew

EVP, Global Operations

Officer
9,989 -100.0%
32.19
US$321,547 		9,989 -100.0% 32.19 US$321,547
2026-06-18 2026-06-18 PrS Proposed sale
Shields Matthew

Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS

Officer
9,989
32.19
US$321,547 		9,989 32.19 US$321,547
2026-06-16 2026-06-11 PlS Planned sale
Kalif Eliyahu Sharon

EVP, Chief Financial Officer

Officer
106,563 -61.9%
34.10
US$3,633,308 		106,563 -61.9% 34.10 US$3,633,308
2026-06-11 2026-06-11 PrS Proposed sale
Kalif Eliyahu Sharon

Officer; EVP CHIEF FINANCIAL OFFICER

Officer
106,563
34.10
US$3,633,305 		106,563 34.10 US$3,633,305
2026-06-11 2026-06-11 PrS Proposed sale
Kalif Eliyahu Sharon

Officer; EVP CHIEF FINANCIAL OFFICER

Officer
106,563
34.10
US$3,633,305 		106,563 34.10 US$3,633,305
2026-06-08 2026-06-05 PlS Planned sale
Francis Richard D

President and CEO

Officer
6,153 -0.5%
34.35
US$211,356 		6,153 -0.5% 34.35 US$211,356
2026-06-05 2026-06-05 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
6,153
34.35
US$211,356 		6,153 34.35 US$211,356
2026-06-04 2026-06-03 PlS Planned sale
Shields Matthew

EVP, Global Operations

Officer
16,195 -61.9%
32.87
US$532,330 		16,195 -61.9% 32.87 US$532,330
2026-06-03 2026-06-03 PrS Proposed sale
Shields Matthew

Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS

Officer
16,195
32.87
US$532,330 		16,195 32.87 US$532,330
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
35,912 -44.8%
35.58
US$1,277,900 		35,912 -44.8% 35.58 US$1,277,900
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
35,912 -44.8%
35.58
US$1,277,900 		35,912 -44.8% 35.58 US$1,277,900
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
5,746 -48.5%
35.58
US$204,467 		5,746 -48.5% 35.58 US$204,467
2026-05-18 2026-05-14 PlS Planned sale
Lippman Evan

EVP, Business Development

Officer
5,746 -48.5%
35.58
US$204,467 		5,746 -48.5% 35.58 US$204,467
2026-05-18 2026-05-14 PlS Planned sale
Kalif Eliyahu Sharon

EVP, Chief Financial Officer

Officer
153,251 -47.1%
35.61
US$5,457,375 		153,251 -47.1% 35.61 US$5,457,375
2026-05-14 2026-05-14 PrS Proposed sale
Lippman Evan

Officer; EXECUTIVE VP BUSINESS DEVELOPMENT

Officer
41,658
35.58
US$1,482,367 		41,658 35.58 US$1,482,367
2026-05-14 2026-05-14 PrS Proposed sale
Kalif Eliyahu Sharon

Officer; EVP CHIEF FINANCIAL OFFICER

Officer
153,251
35.61
US$5,457,369 		153,251 35.61 US$5,457,369
2026-05-07 2026-05-06 S Sale
Weiss Amir

Chief Accounting Officer

Officer
10,679 -34.8%
36.00
US$384,444 		10,679 -34.8% 36.00 US$384,444
2026-05-07 2026-05-05 S Sale
Daniell Richard

EVP, Europe Commercial

Officer
30,000 -35.0%
35.40
US$1,062,000 		30,000 -35.0% 35.40 US$1,062,000
2026-05-05 2026-05-05 PrS Proposed sale
Daniell Richard

Officer; EXECUTIVE VP EUROPEAN COMMERCIAL

Officer
30,000
35.40
US$1,062,000 		30,000 35.40 US$1,062,000
2026-05-04 2026-05-01 S Sale
Sabag Mark

See "Remarks"

Officer
144,180 -64.1%
34.99
US$5,045,118 		144,180 -64.1% 34.99 US$5,045,118
2026-05-04 2026-05-01 PrS Proposed sale
Sabag Mark

Officer; EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL

Officer
144,180
34.99
US$5,045,123 		144,180 34.99 US$5,045,123
2026-05-04 2026-04-30 S Sale
Fox Christine

EVP, U.S. Commercial

Officer
21,258 -25.0%
35.31
US$750,620 		21,258 -25.0% 35.31 US$750,620
2026-04-30 2026-04-30 PrS Proposed sale
Christine Fox

Officer

Officer
21,258
35.31
US$750,633 		21,258 35.31 US$750,633
2026-03-19 2026-03-17 S Sale
Sabag Mark

See "Remarks"

Officer
62,102 -21.6%
30.14
US$1,871,816 		62,102 -21.6% 30.14 US$1,871,816
2026-03-17 2026-03-17 PrS Proposed sale
Sabag Mark

Officer; EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL

Officer
62,102
30.14
US$1,871,815 		62,102 30.14 US$1,871,815
2026-03-09 2026-03-05 PlS Planned sale
Francis Richard D

President and CEO

Officer
20,025 -1.7%
31.67
US$634,160 		20,025 -1.7% 31.67 US$634,160
2026-03-09 2026-03-05 PlS Planned sale
Fox Christine

EVP, U.S. Commercial

Officer
7,924 -8.5%
31.67
US$250,940 		7,924 -8.5% 31.67 US$250,940
2026-03-09 2026-03-05 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
9,533 -8.1%
31.67
US$301,895 		9,533 -8.1% 31.67 US$301,895
2026-03-09 2026-03-05 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
17,295 -16.8%
31.67
US$547,705 		17,295 -16.8% 31.67 US$547,705
2026-03-09 2026-03-05 PlS Planned sale
Jover Placid

See "Remarks"

Officer
14,150 -67.6%
31.67
US$448,108 		14,150 -67.6% 31.67 US$448,108
2026-03-09 2026-03-05 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,127 -9.4%
31.67
US$35,690 		1,127 -9.4% 31.67 US$35,690
2026-03-09 2026-03-05 PlS Planned sale
Shields Matthew

EVP, Global Operations

Officer
17,295 -63.4%
31.67
US$547,705 		17,295 -63.4% 31.67 US$547,705
2026-03-05 2026-03-05 PrS Proposed sale
Shields Matthew

Officer; EXECUTIVE VP TEVA GLOBAL OPERATIONS

Officer
17,295
31.67
US$547,705 		17,295 31.67 US$547,705
2026-03-05 2026-03-05 PrS Proposed sale
Jover Placid

Officer; EXECUTIVE VP CHIEF HUMAN RESOURCES OFFICER

Officer
14,150
31.67
US$448,108 		14,150 31.67 US$448,108
2026-03-05 2026-03-05 PrS Proposed sale
Savage Brian

Officer; INTERIM CHIEF LEGAL OFFICER

Officer
1,127
31.67
US$35,690 		1,127 31.67 US$35,690
2026-03-05 2026-03-05 PrS Proposed sale
Fox Christine

Officer; EVP HEAD OF US COMMERCIAL

Officer
7,924
31.67
US$250,940 		7,924 31.67 US$250,940
2026-03-05 2026-03-05 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
20,025
31.67
US$634,160 		20,025 31.67 US$634,160
2026-03-05 2026-03-05 PrS Proposed sale
Hughes Eric A

Officer; EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER

Officer
9,533
31.67
US$301,895 		9,533 31.67 US$301,895
2026-03-05 2026-03-05 PrS Proposed sale
Daniell Richard

Officer; EXECUTIVE VP EUROPEAN COMMERCIAL

Officer
17,295
31.67
US$547,705 		17,295 31.67 US$547,705
2026-03-06 2026-03-04 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
37,372 -30.4%
32.95
US$1,231,310 		37,372 -30.4% 32.95 US$1,231,310
2026-03-06 2026-03-04 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
20,461 -14.2%
32.46
US$664,256 		20,461 -14.2% 32.46 US$664,256
2026-03-06 2026-03-04 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
33,512 -21.4%
32.46
US$1,087,950 		33,512 -21.4% 32.46 US$1,087,950
2026-03-06 2026-03-04 PlS Planned sale
Francis Richard D

President and CEO

Officer
23,393 -2.0%
32.46
US$759,442 		23,393 -2.0% 32.46 US$759,442
2026-03-06 2026-03-04 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
11,277 -10.4%
32.46
US$366,102 		11,277 -10.4% 32.46 US$366,102
2026-03-06 2026-03-04 PlS Planned sale
Fox Christine

EVP, U.S. Commercial

Officer
9,098 -10.8%
32.46
US$295,362 		9,098 -10.8% 32.46 US$295,362
2026-03-06 2026-03-04 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,186 -12.3%
32.46
US$38,503 		1,186 -12.3% 32.46 US$38,503
2026-03-06 2026-03-04 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,489 -19.4%
32.46
US$48,340 		1,489 -19.4% 32.46 US$48,340
2026-03-04 2026-03-04 PrS Proposed sale
Fox Christine

Officer; EVP HEAD OF US COMMERCIAL

Officer
9,908
32.46
US$321,658 		9,908 32.46 US$321,658
2026-03-04 2026-03-04 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
23,393
32.46
US$759,442 		23,393 32.46 US$759,442
2026-03-04 2026-03-04 PrS Proposed sale
Hughes Eric A

Officer; EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER

Officer
11,277
32.46
US$366,102 		11,277 32.46 US$366,102
2026-03-04 2026-03-04 PrS Proposed sale
Daniell Richard

Officer; EXECUTIVE VP EUROPEAN COMMERCIAL

Officer
91,345
32.66
US$2,983,516 		91,345 32.66 US$2,983,516
2026-03-05 2026-03-03 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
66,735 -35.1%
32.36
US$2,159,538 		66,735 -35.1% 32.36 US$2,159,538
2026-03-05 2026-03-03 PlS Planned sale
Daniell Richard

EVP, Europe Commercial

Officer
62,250 -56.3%
32.36
US$2,014,404 		62,250 -56.3% 32.36 US$2,014,404
2026-03-05 2026-03-03 S Sale
Savage Brian

Interim Chief Legal Officer

Officer
1,274 -30.3%
32.36
US$41,227 		1,274 -30.3% 32.36 US$41,227
2026-03-05 2026-03-03 PlS Planned sale
Francis Richard D

President and CEO

Officer
412,032 -26.9%
32.36
US$13,333,314 		412,032 -26.9% 32.36 US$13,333,314
2026-03-05 2026-03-03 PlS Planned sale
Francis Richard D

President and CEO

Officer
30,903 -4.6%
32.36
US$1,000,018 		30,903 -4.6% 32.36 US$1,000,018
2026-03-05 2026-03-03 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
68,685 -44.5%
32.36
US$2,222,640 		68,685 -44.5% 32.36 US$2,222,640
2026-03-05 2026-03-03 PlS Planned sale
Hughes Eric A

See "Remarks"

Officer
12,077 -48.5%
32.36
US$390,811 		12,077 -48.5% 32.36 US$390,811
2026-03-03 2026-03-03 PrS Proposed sale
Savage Brian

Officer; EXECUTIVE VP INTERIM CHIEF LEGAL OFFICER

Officer
1,274
32.36
US$41,227 		1,274 32.36 US$41,227
2026-03-03 2026-03-03 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
442,935
32.36
US$14,333,332 		442,935 32.36 US$14,333,332
2026-03-03 2026-03-03 PrS Proposed sale
Hughes Eric A

Officer; EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER

Officer
80,762
32.36
US$2,613,450 		80,762 32.36 US$2,613,450
2026-03-03 2026-03-03 PrS Proposed sale
Daniell Richard

Officer; EXECUTIVE VP EUROPEAN COMMERCIAL

Officer
128,985
32.36
US$4,173,942 		128,985 32.36 US$4,173,942
2026-03-02 2026-02-26 PlS Planned sale
Kalif Eliyahu Sharon

EVP, Chief Financial Officer

Officer
345,810 -85.7%
33.64
US$11,634,708 		345,810 -85.7% 33.64 US$11,634,708
2026-02-26 2026-02-26 PrS Proposed sale
Kalif Eliyahu Sharon

Officer; EVP CHIEF FINANCIAL OFFICER

Officer
345,810
33.64
US$11,634,702 		345,810 33.64 US$11,634,702
2026-02-18 2026-02-17 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
447,778
34.22
US$15,324,798 		447,778 34.22 US$15,324,798
2026-02-18 2026-02-17 PrS Proposed sale
Francis Richard D

Officer; PRESIDENT AND CEO

Officer
447,778
1.00
US$447,778 		447,778 1.00 US$447,778
2026-02-18 2026-02-15 PlS Planned sale
Francis Richard D

President and CEO

Officer
286,122 -32.1%
34.22
US$9,792,268 		286,122 -32.1% 34.22 US$9,792,268
2026-02-18 2026-02-15 PlS Planned sale
Francis Richard D

President and CEO

Officer
161,656 -37.3%
34.22
US$5,532,531 		161,656 -37.3% 34.22 US$5,532,531
2025-12-18 2025-12-16 S Sale
Weiss Amir

Chief Accounting Officer

Officer
12,300 -68.5%
30.20
US$371,504 		12,300 -68.5% 30.20 US$371,504
Explore more

More insider trading research around Teva Pharmaceutical Industries Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America